ENvue Medical (FEED) Net Income towards Common Stockholders (2014 - 2026)
ENvue Medical's (FEED) quarterly Net Income towards Common Stockholders came in at -$22.6 million in Q1 2026, down 1108.39% year-on-year from $2.2 million in Q1 2025, and down 66.05% on a QoQ basis from -$13.6 million in Q4 2025.
ENvue Medical (FEED) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 13 years of Net Income towards Common Stockholders data on file, last reported at -$22.6 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 1108.39% year-over-year to -$22.6 million in Q1 2026; TTM through Mar 2026 was -$37.5 million, a 652.13% decrease from a year earlier, with the FY2025 full-year figure at -$16.8 million, down 352.77% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$22.6 million, down from -$13.6 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for FEED reached as high as -$500000.0 in Q2 2025 and fell as low as -$22.6 million in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged -$3.1 million across 5 years, with a median of -$1.1 million in 2023.
- Across the five-year window, Net Income towards Common Stockholders surged 85.69% in 2022 and plunged 1108.39% in 2026, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$2.1 million in 2022, then soared by 60.51% to -$813000.0 in 2023, then sank by 76.01% to -$1.4 million in 2024, then plunged by 851.99% to -$13.6 million in 2025, then slumped by 66.05% to -$22.6 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$22.6 million in Q1 2026, -$13.6 million in Q4 2025, and -$780000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 176.78 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ENvue Medical | 10,254.30 | -2.25 Mn | -55,000.00 | -22.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.62 Mn |
| Dec 31, 2025 | -13.62 Mn |
| Sep 30, 2025 | -780,000.00 |
| Jun 30, 2025 | -500,000.00 |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Sep 30, 2024 | -998,000.00 |
| Jun 30, 2024 | -688,000.00 |
| Mar 31, 2024 | -588,000.00 |
| Dec 31, 2023 | -813,000.00 |
| Sep 30, 2023 | -727,000.00 |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -2.06 Mn |
| Sep 30, 2022 | -955,000.00 |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | -2.47 Mn |
| Sep 30, 2021 | -6.67 Mn |
| Jun 30, 2021 | -230,000.00 |